Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Payables (2016 - 2025)

Historic Payables for Eastman Chemical (EMN) over the last 17 years, with Q4 2025 value amounting to $2.7 billion.

  • Eastman Chemical's Payables fell 206.79% to $2.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.7 billion, marking a year-over-year decrease of 206.79%. This contributed to the annual value of $2.7 billion for FY2025, which is 206.79% down from last year.
  • According to the latest figures from Q4 2025, Eastman Chemical's Payables is $2.7 billion, which was down 206.79% from $2.2 billion recorded in Q3 2025.
  • In the past 5 years, Eastman Chemical's Payables registered a high of $3.3 billion during Q4 2022, and its lowest value of $2.0 billion during Q1 2021.
  • Over the past 5 years, Eastman Chemical's median Payables value was $2.7 billion (recorded in 2024), while the average stood at $2.7 billion.
  • In the last 5 years, Eastman Chemical's Payables soared by 6858.58% in 2021 and then tumbled by 2076.28% in 2023.
  • Eastman Chemical's Payables (Quarter) stood at $2.9 billion in 2021, then increased by 12.88% to $3.3 billion in 2022, then dropped by 20.76% to $2.6 billion in 2023, then grew by 5.12% to $2.7 billion in 2024, then dropped by 2.07% to $2.7 billion in 2025.
  • Its Payables stands at $2.7 billion for Q4 2025, versus $2.2 billion for Q3 2025 and $2.4 billion for Q2 2025.